BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11290870)

  • 1. Antitumor activity, optimum administration method and pharmacokinetics of 13,14-dihydro-15-deoxy-deoxy-Delta7 -prostaglandin A1 methyl ester (TEI-9826) integrated in lipid microspheres (Lipo TEI-9826).
    Fukushima S; Takeuchi Y; Kishimoto S; Yamashita S; Uetsuki K; Shirakawa S; Suzuki M; Furuta K; Noyori R; Sasaki H; Kikuchi Y; Kita T; Yamori T; Sawada J; Kojima M; Hazato A; Kurozumi S; Fukushima M
    Anticancer Drugs; 2001 Mar; 12(3):221-34. PubMed ID: 11290870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of o/w type emulsions containing antitumor prostaglandin.
    Fukushima S; Kishimoto S; Takeuchi Y; Fukushima M
    Adv Drug Deliv Rev; 2000 Dec; 45(1):65-75. PubMed ID: 11104898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of 13,14-dihydro-15-deoxy-delta7-prostaglandin-A1-methyl ester integrated into lipid microspheres against human ovarian carcinoma cells resistant to cisplatin in vivo.
    Sasaki H; Niimi S; Akiyama M; Tanaka T; Hazato A; Kurozumi S; Fukushima S; Fukushima M
    Cancer Res; 1999 Aug; 59(16):3919-22. PubMed ID: 10463583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmaceutical and pharmacological development of antitumor prostaglandins].
    Fukushima S; Kishimoto S; Takeuchi Y; Fukushima M; Suzuki M; Furuta K; Noyori R; Sasaki H; Kikuchi Y; Nakano M; Kurozumi S
    Nihon Rinsho; 1998 Mar; 56(3):663-9. PubMed ID: 9549353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandins in the treatment of cancer.
    Sasaki H; Fukushima M
    Anticancer Drugs; 1994 Apr; 5(2):131-8. PubMed ID: 8049495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of two dosage forms containing antitumor prostaglandin and their antitumor effect in vitro and in vivo: Lipiodol solution for i.a. administration and lipid microspheres for i.p. or i.v. administration.
    Shoji F; Masahiro N; Yoshikazu T; Masanori F
    Adv Exp Med Biol; 1997; 400B():955-61. PubMed ID: 9547652
    [No Abstract]   [Full Text] [Related]  

  • 7. Antitumor activity of delta 7-prostaglandin A1 and delta 12-prostaglandin J2 in vitro and in vivo.
    Kato T; Fukushima M; Kurozumi S; Noyori R
    Cancer Res; 1986 Jul; 46(7):3538-42. PubMed ID: 3708585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human ovarian cancer cell lines resistant to cisplatin, doxorubicin, and L-phenylalanine mustard are sensitive to delta 7-prostaglandin A1 and delta 12-prostaglandin J2.
    Sasaki H; Takada K; Terashima Y; Ekimoto H; Takahashi K; Tsuruo T; Fukushima M
    Gynecol Oncol; 1991 Apr; 41(1):36-40. PubMed ID: 2026357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged survival time of sarcoma 180-bearing mice treated with lipid microspheres-entrapped antitumor marine coral prostanoids.
    Honda A; Mori Y; Yamada Y; Nakaike S; Hayashi H; Otomo S
    Res Commun Chem Pathol Pharmacol; 1988 Sep; 61(3):413-6. PubMed ID: 3187200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human melanoma growth by prostaglandin A, D, and J analogues.
    Bregman MD; Funk C; Fukushima M
    Cancer Res; 1986 Jun; 46(6):2740-4. PubMed ID: 3698005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of lipid microspheres as a drug carrier for antitumour drugs.
    Mizushima Y; Shoji Y; Kato T; Fukushima M; Kurozumi S
    J Pharm Pharmacol; 1986 Feb; 38(2):132-4. PubMed ID: 2870158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and antitumor properties in tumor-bearing mice of an enediol analogue inhibitor of glyoxalase I.
    Sharkey EM; O'Neill HB; Kavarana MJ; Wang H; Creighton DJ; Sentz DL; Eiseman JL
    Cancer Chemother Pharmacol; 2000; 46(2):156-66. PubMed ID: 10972486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) adenine, a novel deoxyadenosine analog, against human colon tumor xenografts by oral administration.
    Takahashi T; Kanazawa J; Akinaga S; Tamaoki T; Okabe M
    Cancer Chemother Pharmacol; 1999; 43(3):233-40. PubMed ID: 9923554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft.
    Luo FR; Yang Z; Dong H; Camuso A; McGlinchey K; Fager K; Flefleh C; Kan D; Inigo I; Castaneda S; Rose WC; Kramer RA; Wild R; Lee FY
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):455-64. PubMed ID: 15947929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity.
    Kim TH; Jiang HH; Park CW; Youn YS; Lee S; Chen X; Lee KC
    J Control Release; 2011 Feb; 150(1):63-9. PubMed ID: 21062635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEGylated lipid microspheres loaded with cabazitaxel for intravenous administration: stability, bioavailability, antitumor efficacy, and toxicity.
    Liu Y; Xie B; Li L; Zhang X; Zhang Y; He H; Yin T; Tang X; Cai C; Gou J
    Drug Deliv Transl Res; 2018 Oct; 8(5):1365-1379. PubMed ID: 30019282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacodynamics, pharmacokinetics and tissue distribution of liposomal mitoxantrone hydrochloride].
    Wang CX; Li CL; Zhao X; Yang HY; Wei N; Li YH; Zhang L; Zhang L
    Yao Xue Xue Bao; 2010 Dec; 45(12):1565-9. PubMed ID: 21351498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo anti-platelet effects of isocarbacyclin methyl ester incorporated in lipid microspheres in rabbits.
    Inoue K; Aoki Y; Hayashi M; Kitahara S; Tanabe H; Kiyoki M; Araki H
    Arzneimittelforschung; 1995 Sep; 45(9):980-4. PubMed ID: 7488317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulation of the topoisomerase I inhibitor GL147211C in pegylated (STEALTH) liposomes: pharmacokinetics and antitumor activity in HT29 colon tumor xenografts.
    Colbern GT; Dykes DJ; Engbers C; Musterer R; Hiller A; Pegg E; Saville R; Weng S; Luzzio M; Uster P; Amantea M; Working PK
    Clin Cancer Res; 1998 Dec; 4(12):3077-82. PubMed ID: 9865923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasorelaxant effect of isocarbacyclin methyl ester incorporated into lipid microspheres on isolated canine arteries.
    Sawada K; Aoki K; Katsuura Y; Tanabe H; Kiyoki M; Araki H
    Arzneimittelforschung; 1995 Sep; 45(9):985-8. PubMed ID: 7488318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.